Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?
Daniel D L Bernal1, Luke R E Bereznicki2, Leanne Chalmers2
1Unit for Medication Outcomes Research and Education (UMORE), Pharmacy, School of Medicine, University of Tasmania, Private Bag 26, Hobart, TAS, 7001, Australia. daniel.bernal@utas.edu.au.
Insights
Strict adherence to acute coronary syndrome (ACS) guidelines may hinder personalized treatment. Identifying patient barriers to medication adherence is key to realizing guideline benefits and individualizing therapy for better outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Guideline-based management for acute coronary syndrome (ACS) is standard practice.
- Strict adherence to ACS guidelines may limit individualized patient therapy.
- Medication non-adherence can prevent patients from achieving the full benefits of ACS treatment.
Purpose of the Study:
- To explore the challenges of strict guideline implementation in ACS management.
- To highlight the importance of identifying and addressing medication adherence barriers in ACS patients.
- To introduce the World Health Organization's model for adherence barriers as a tool for individualizing therapy.
Main Methods:
- A case example is used to illustrate the process of identifying adherence barriers.
- The World Health Organization's model of adherence barriers is discussed.
- The potential for this model to aid in therapy individualization and adherence promotion is explored.
Main Results:
- Recognizing adherence barriers is an effective method for identifying patients at risk of non-adherence post-ACS.
- The WHO model offers a framework for understanding and addressing diverse adherence challenges.
- Individualizing therapy based on identified barriers can improve medication adherence.
Conclusions:
- Addressing medication adherence barriers is crucial for optimizing ACS patient outcomes.
- The WHO model can guide clinicians in tailoring ACS treatment plans.
- Personalized approaches to therapy are essential for maximizing the effectiveness of guideline-based ACS care.
Abstract:
Guideline-based management of acute coronary syndrome (ACS) is well established, yet some may challenge that strict implementation of guideline recommendations can limit the individualization of therapy. The use of all recommended medications following ACS places a high burden of responsibility and cost on patients, particularly when these medications have not been previously prescribed. Without close attention to avoiding non-adherence to these medications, the full benefits of the guideline recommendations will not be realized in many patients. Using a case example, we discuss how the recognition of adherence barriers can be an effective and efficient process for identifying patients at risk of non-adherence following ACS. For those identified as at risk, the World Health Organization's model of adherence barriers is explored as a potentially useful tool to assist with individualization of therapy and promotion of adherence.
More Related Videos
07:59Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:27Coronary Artery Disease V: Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome I: Introduction